` NXNN (Nexeon Medsystems Inc) vs S&P 500 Comparison - Alpha Spread

NXNN
vs
S&P 500

Over the past 12 months, NXNN has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's 12% growth.

Stocks Performance
NXNN vs S&P 500

Loading
NXNN
S&P 500
Add Stock

Performance Gap
NXNN vs S&P 500

Loading
NXNN
S&P 500
Difference

Performance By Year
NXNN vs S&P 500

Loading
NXNN
S&P 500
Add Stock

Competitors Performance
Nexeon Medsystems Inc vs Peers

Nexeon Medsystems Inc
Glance View

Market Cap
196.6 USD
Industry
Health Care

Nexeon MedSystems, Inc. is a medical device company, which focuses on the development, manufacturing, and commercialization of neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. The company is headquartered in West Palm Beach, Florida. The company went IPO on 2017-08-01. The Company’s developing technology solutions device including electronics, software, mechanical engineering, and material science, as well as pharmaceuticals, protein chemistry, and cell biology. In addition, the Company is developing and commercializing NNS, an implantable neurostimulation and recording platform. The Company’s wholly-owned subsidiaries include Nexeon Medsystems Europe, SARL (Nexeon Europe), Nexeon Medsystems Puerto Rico Operating Company Corporation (NXPROC) and Pulsus Medical LLC.

NXNN Intrinsic Value
Not Available
N
Back to Top